British Pharmacopoeia publishing: MHRA plans a concession for 2029-2035
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Competitive flexible procedure
- 31 March 2027 to 31 March 2032
The Medicines and Healthcare products Regulatory Agency (MHRA) plans to let a concession to publish, sell and market the British Pharmacopoeia. The concession covers the 2029 to 2035 editions.
The MHRA says the opportunity suits small businesses. It estimates the concession at £39.81m. The concession would start in March 2027 and could be extended by two 12-month periods to March 2034.
- What
- Publishing services for books, journals and reports
- Estimated value
- £39.8m
- How it will be bought
- Competitive flexible procedure
- Responses due
- 4 Nov 2026
- Contract dates
- Mar 2027 to Mar 2032
- Option to Mar 2034